These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25105381)

  • 1. Recurrent urothelial cell carcinoma presenting with gastrointestinal symptoms.
    Asfour R; Stettler G; Pinzon MM; Hayden D; Eberhardt J; Saclarides T; Slogoff M
    Am Surg; 2014 Aug; 80(8):E240-2. PubMed ID: 25105381
    [No Abstract]   [Full Text] [Related]  

  • 2. [Annular constriction of the rectum secondary to urothelial carcinoma of the bladder].
    Ito Y; Nishimoto K; Ogata K; Fujioka T
    Hinyokika Kiyo; 2008 Aug; 54(8):553-5. PubMed ID: 18788446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patient with acquired factor X deficiency and metastatic transitional cell carcinoma of the bladder: is there a link between metastasis and factor deficiency in solid tumors?
    Cammaert T; Decaestecker K; Sundahl N; Rottey S; Devreese KMJ
    Ann Hematol; 2018 Mar; 97(3):545-546. PubMed ID: 29130135
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiac metastasis of a recurrent urothelial carcinoma of the bladder].
    Schreiner M; Schneider B; Pauls S
    Rofo; 2015 Dec; 187(12):1124-6. PubMed ID: 26425856
    [No Abstract]   [Full Text] [Related]  

  • 5. Urothelial cancer producing granulocyte colony-stimulating factor: possible induction of splenomegaly.
    Kitayama S; Fujii Y; Kihara K
    Urology; 2004 Feb; 63(2):377-8. PubMed ID: 14972497
    [No Abstract]   [Full Text] [Related]  

  • 6. Bladder wall calcification after topical mitomycin C.
    Alter AJ; Malek GH
    J Urol; 1987 Nov; 138(5):1239-40. PubMed ID: 3118058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guideline on urothelial carcinoma of the bladder].
    Bevers RF; Battermann JJ; Gietema JA; Hulsbergen-Van de Kaa CA; de Reijke TM; Feller N; Witjes JA; ;
    Ned Tijdschr Geneeskd; 2009; 153():A956. PubMed ID: 20051162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation criteria: a protocol to study patterns of care and their effects in patients with transitional cell carcinoma of the bladder (protocol 1).
    Prout GR; Kopp J
    Prog Clin Biol Res; 1984; 162A():285-99. PubMed ID: 6483913
    [No Abstract]   [Full Text] [Related]  

  • 9. [Leukemoid reaction as a paraneoplastic manifestation of bladder carcinoma].
    Caballero Alcántara JE; Castro Pita MA; Carrero López V; Rodríguez Antolin A; Pamplona Casamayor M; Leiva Galvis O
    Actas Urol Esp; 1991; 15(5):496-9. PubMed ID: 1807134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What place can chemotherapy occupy in the treatment of infiltrating transitional carcinoma of the bladder?].
    Escudero Barrilero A; Jiménez Cidre M; Gutiérrez Sanz-Gadea C; Mateos Torres A; Maganto Pavón E; Mayayo Dehesa T; Allona Almagro A
    Arch Esp Urol; 1986; 39(9):617-27. PubMed ID: 3827327
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bladder cancer associated with von Recklinghausen's disease: a case report].
    Yonemura S; Okuno T; Yamada Y; Uchida K; Arima K; Yanagawa M; Kawamura J
    Hinyokika Kiyo; 1997 Aug; 43(8):585-8. PubMed ID: 9310783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urothelial malignancy--much promise but little progress.
    Bahnson RR
    J Urol; 1996 Jan; 155(1):122. PubMed ID: 7490807
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
    Simon SD; Srougi M
    Prog Clin Biol Res; 1990; 353():169-74. PubMed ID: 2217415
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
    Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Bladder cancer. How can we make a difference?
    Soloway MS
    J Urol; 2003 Nov; 170(5):1781-2. PubMed ID: 14532775
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of chemotherapy-refractory metastatic urothelial tumors.
    Logothetis C
    Urol Clin North Am; 1992 Nov; 19(4):775-7. PubMed ID: 1441031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraneoplastic leukemoid reaction as marker for transitional cell carcinoma recurrence.
    Dukes JW; Tierney LM
    Urology; 2009 Apr; 73(4):928.e17-9. PubMed ID: 18718647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative tumor board: transitional cell carcinoma of the bladder.
    Feng AY; Hogan TF; Lamm DL; Yarnell E; Philhower M; Krise M; Lundy VJ; Block KI
    Integr Cancer Ther; 2005 Mar; 4(1):48-64. PubMed ID: 15835094
    [No Abstract]   [Full Text] [Related]  

  • 19. Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review.
    Bientinesi R; Ragonese M; Pinto F; Bassi PF; Sacco E
    Clin Genitourin Cancer; 2016 Apr; 14(2):e199-201. PubMed ID: 26707952
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intra-diverticular urothelial tumors of the bladder].
    Bouchot O; Zerbib M
    Prog Urol; 2002 Nov; 12(5):1109-11. PubMed ID: 12536933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.